0 Комментарии
0 Поделились
218 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Antibody-Drug Conjugate (ADC) Oncology Market: Trends and Growth OpportunitiesExecutive Summary Antibody-Drug Conjugate (ADC) Oncology Market Research: Share and Size Intelligence CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of 10.80% during the forecast period The scope of this Antibody-Drug Conjugate...0 Комментарии 0 Поделились 244 Просмотры 0 предпросмотр
-
Asia Pacific CRO Market - Oncology Trial Demand Driving Specialized CRO Capability DevelopmentMarket Overview The Asia Pacific contract research organization market is experiencing significant growth from oncology clinical trial activity as Asia Pacific's large cancer patient populations and established oncology research infrastructure attract increasing global and regional pharmaceutical oncology development investment. The Asia Pacific CRO market is projected to surpass USD 12...0 Комментарии 0 Поделились 80 Просмотры 0 предпросмотр
-
Cancer Research Breakthrough: Evaluating the Critical Role of Spheroids and Organoids in Personalized Oncology and Therapy Development.For 3D cell culture models to transition from specialized research tools to mainstream industry standards in pharmaceutical R&D, they must be scalable for High-Throughput Screening (HTS). The inherent complexity and manual handling requirements of 3D cultures—such as precise media changes, matrix embedding, and complex imaging—initially made them difficult to integrate into the...0 Комментарии 0 Поделились 846 Просмотры 0 предпросмотр
-
CD47 Targeting Therapeutics Market Analysis and Immuno-Oncology LandscapeThe CD47 Targeting Therapeutics Market analysis highlights the growing significance of CD47 as a promising target in cancer immunotherapy. CD47, often referred to as the “don’t eat me” signal, is overexpressed in many cancer cells, allowing them to evade immune system clearance. Therapeutics targeting CD47 aim to block this signal, enabling macrophages to recognize and...0 Комментарии 0 Поделились 485 Просмотры 0 предпросмотр
-
CDx Beyond Oncology: Expanding into Rare Diseases and Neurodegenerative Disorders – New Market FrontiersCompanion diagnostics (CDx) are transcending their oncology roots, expanding into new disease areas like rare genetic disorders and neurodegenerative conditions, where precise patient stratification is critical. This shift is driven by advancements in biomarker discovery and growing demand for personalized treatments in underserved fields. As CDx proves its utility beyond cancer, the market is...0 Комментарии 0 Поделились 933 Просмотры 0 предпросмотр
-
Chemotherapy Drug Market Advances Through Continuous Oncology Treatment Innovations" According to the latest report published by Data Bridge Market Research, the Chemotherapy Drug Market CAGR Value Data Bridge Market Research analyses that the chemotherapy drug market which was USD 47,028.67 million in 2022, would rocket up to USD 97,914.53 million by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. Chemotherapy Drug Marketing report...0 Комментарии 0 Поделились 121 Просмотры 0 предпросмотр
-
Chemotherapy Drug Market Progresses with Continuous Oncology Treatment Developments" According to the latest report published by Data Bridge Market Research, the Chemotherapy Drug Market CAGR Value Data Bridge Market Research analyses that the chemotherapy drug market which was USD 47,028.67 million in 2022, would rocket up to USD 97,914.53 million by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. Market definition mentioned in this...0 Комментарии 0 Поделились 75 Просмотры 0 предпросмотр
-
Companion Diagnostics Market - Oncology Pipeline Expansion Accelerating Companion Diagnostic DemandMarket Overview The global companion diagnostics market is expanding rapidly as oncology drug pipelines proliferate and targeted therapy approvals increasingly mandate paired diagnostic validation. The global companion diagnostics market is expected to exceed USD 10 billion through 2030, driven by surging cancer incidence globally, growing pharmaceutical investment in targeted biologics...0 Комментарии 0 Поделились 80 Просмотры 0 предпросмотр
-
Global Immuno-Oncology Assay Market Forecast 2030: Growth Trends, Key Players & Future Outlook | MarkNtelAs per MarkNtel Advisors The Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30. Global Immuno-Oncology Assay Market Systems Market Outlook: The Russian Seed Market is rapidly...0 Комментарии 0 Поделились 789 Просмотры 0 предпросмотр
-
Hadron Therapy Market Growth Driven by Demand for Targeted Oncology SolutionsThe continuous advancement in targeted cancer therapy solutions has placed hadron-based radiation techniques at the forefront of next-generation oncology care. The Hadron Therapy Market research shows that proton and carbon-ion therapies are expanding rapidly due to their superior delivery accuracy and reduced side effects compared to conventional radiotherapy. As the global burden of cancer...0 Комментарии 0 Поделились 953 Просмотры 0 предпросмотр
-
Harnessing Quantitative Information for Strategic Decisions: Analyzing China Companion Diagnostics Oncology Market DataThe effective utilization of granular, verified information is the bedrock of successful commercial strategy in China’s oncology diagnostics sector. China Companion Diagnostics Oncology Market Data provides the quantitative backbone necessary to move beyond anecdotal evidence and make evidence-based decisions regarding product development, pricing, and distribution. This data...0 Комментарии 0 Поделились 957 Просмотры 0 предпросмотр
-
Alpha Emitter Market: Tripling to $3.09 Billion by 2032ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Basal Cell Carcinoma Treatment Market Size Projected to Reach USD 8.96 Billion by 2032The global Basal Cell Carcinoma Treatment Market comprises the diagnosis and management solutions for Basal Cell Carcinoma, the most common form of skin cancer worldwide. BCC arises from the uncontrolled growth of basal cells, typically appearing on sun-exposed areas of the skin. Treatment modalities range from surgical removal for localized lesions to pharmacological agents and radiation...0 Комментарии 0 Поделились 848 Просмотры 0 предпросмотр
-
Cell Therapy Manufacturing Market: Global Growth & AnalysisIntrospective Market Research, a global authority in biotechnology and healthcare analysis, today released its comprehensive report on the Global Cell Therapy Manufacturing Market. This critical sector, which encompasses the complex processes of cell acquisition, culture, expansion, and testing for regenerative medicine, is transitioning from a niche laboratory process to an industrialized...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Clinical Nutrition Market - Industry Growth & Trend AnalysisIntrospective Market Research, a leader in specialized healthcare market intelligence, today announced the release of its definitive report on the Global Clinical Nutrition Market. This critical sector, which ensures patients receive necessary dietary support during illness and recovery, was valued at USD 30.13 Billion in 2023. With chronic diseases and an increasing geriatric population...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Colorectal Cancer Treatment Market Advances with Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Colorectal Cancer Treatment Market Progresses with Advances in Targeted and ImmunotherapiesRegional Overview of Executive Summary Colorectal Cancer Treatment Market by Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. Colorectal Cancer Treatment Market analysis gives a clear idea on various segments...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
DNA Sequencing Market - Latest Advancement And AnalysisIntrospective Market Research, a global provider of specialized market intelligence, today released a pivotal study on the global DNA Sequencing Market. The report reveals a genomic revolution underway, driven by a dramatic reduction in sequencing costs and the increasing integration of sophisticated bioinformatics. The market, which stood at USD 11.1 Billion in 2023, is forecast to reach USD...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Clinical NGS Testing Market Surges with Precision Medicine Growth and Faster Genetic DiagnosticsDetailed Analysis of Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period With this Clinical...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global Colorectal Cancer Treatment Market Advances with Targeted Therapies, Immunotherapy, and Early DiagnosisComprehensive Outlook on Executive Summary Colorectal Cancer Treatment Market Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. The insights provided in this Colorectal Cancer Treatment Market research...0 Комментарии 0 Поделились 860 Просмотры 0 предпросмотр
-
How Are New Therapies Transforming Treatment in Hodgkin Lymphoma?Global Executive Summary Hodgkin Lymphoma Drug Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029 The global Hodgkin Lymphoma Drug Market analysis report gives a careful overview of the research trends for the financial year. This report studies the...0 Комментарии 0 Поделились 659 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
